Soley Therapeutics Announces $200 Million Series C Financing to Propel Lead Oncology Programs into the Clinic and Scale Its Cell Stress Sensing Platform
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Soley Therapeutics (“Soley”) today announced a $200 million Series C financing to advance its proprietary cell stress sensing platform and pipeline of novel therapeutics into the clinic. Proceeds will support IND-enabling work…
